Indrayani Biotech Ltd
₹8.27▲ +0.12 (+1.47%)
INDRANIB·BSE·FMCG
Market Cap
37.66 Cr
PE Ratio
5.91
Volume
16,151
Day High - Low
8.40 - 8.06
52W High-Low
15.60 - 6.10
₹8.27▲ +0.12 (+1.47%)
Market Cap37.66 Cr
PE Ratio5.91
Volume16,151
Day High - Low8.40 - 8.06
52W High-Low15.60 - 6.10
Indrayani Biotech Ltd (INDRANIB): company summary
The company's annual net profit fell 42.7% while revenue declined 6.0% over three years.
Indrayani Biotech Ltd (INDRANIB) is a micro-cap FMCG company valued at ₹38 crore operating in Agricultural Products on the NSE and BSE.
- Recent price move
- Indrayani Biotech Ltd last traded at ₹8.27, modestly up 1.47% on the day.
- Financial performance
- The company's annual net profit fell 42.7% while revenue declined 6.0% over three years. In the latest quarter, net profit rose 237.5% compared to the same quarter a year earlier, driven by a jump from ₹0 crore to ₹1 crore, while revenue increased 29.6% to ₹38 crore.
- Valuation multiples
- The stock trades at 5.9 times earnings, 0.62 times book value.
- Things to watch
- The company's net profit margin is 1.4%, which is low, and its return on equity is 0.5%, indicating weak profitability. The debt to equity ratio is 1.76, suggesting high leverage. Promoter holding decreased by 0.34 percentage points, and 24.82% of promoter shares are pledged.
- Where it stands
- The company's latest quarter showed a significant rise in net profit, but annual figures show a decline. The stock is 47.8% below its 52-week high, and the debt to equity ratio remains high at 1.76.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
3.9/10
Poor
Fair Value
Sign in to see
ROE
0.52%
Weak
P/E
5.91x
Cheap
Debt / Equity
1.76
High
Industry
FMCG
Agricultural Products
Overall View
Mixed
Price performance
Day₹8.06
₹8.40
52W₹6.10
₹15.60
DocStoX take
Supported by valuation (8.9), but held back by momentum (1.1). Valuation looks strong at 8.9, but that is offset by momentum at 1.1 and quality at 2.3. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence3.9
/10
Poor
Quality
Weak
ROE 0.5%
Valuation
Cheap
P/E 5.9×
Growth
Slow
Revenue +17.7% 5Y CAGR
Risk
Elevated
D/E 1.76
Momentum
Weak
23% of 52-week range
At a glance
Market Cap
₹38 Cr
52W High / Low
₹16 / ₹6
Dividend Yield
0.00%
Promoter Holding
32.92%
EPS (TTM)
₹1.40
Book Value
₹16.01
Key highlights
- Undemanding at 6× earnings
- Revenue compounding 18% a year
- Profit shrinking 13% a year
- High leverage — debt is 1.8× equity
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More FMCG stocks · Agricultural Products
Explore Indrayani Biotech Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Indrayani Biotech Ltd peers in FMCG
Other FMCG stocks on the NSE & BSE. See the full FMCG sector list.
Related tools & concepts
Value Indrayani Biotech Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing